| Net Cash Provided by (Used in) Operating Activities |
$3,260,319 |
USD |
-4.1% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$3,603,695 |
USD |
-76% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
3,100,000,000 |
shares |
|
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
23,195 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$343,376 |
USD |
-125% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$9,739,587 |
USD |
13% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
125 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$845,141 |
USD |
3.9% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
125 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |